Work

Statistical analysis plan considerations for autologous cell and cell-based gene therapy clinical trials

Year: 2026

Type: article

Source: Journal of Biopharmaceutical Statistics

DOI: 10.1080/10543406.2026.2685280

Authors: Patricia Anderson, Revathi Ananthakrishnan, Zhenzhen Xu, Khadija Rerhou Rantell, Susan Bell, Daniel Li, Allen Xue, Alan Y. Chiang

Institutions: ICON PLC (Ireland), Bristol-Myers Squibb (United States), United States Food and Drug Administration, Medicines and Healthcare products Regulatory Agency, Kite Pharma (United States), Lyell Immunopharma (United States)

Language: English

Topic: Statistical Methods in Clinical Trials

Subfield: Statistics and Probability

Field: Mathematics

Domain: Physical Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7169086202

FWCI:

Cites: 17

Cited by:

Related to: